DW Coordinating Center Changes Name to Evidence Clinical and Pharmaceutical Research.

Business Editors & Health/Medical Writers

BIOWIRE2K

LOS ALTOS, Calif.--(BUSINESS WIRE)--Aug. 21, 2002

DW Coordinating Center LLC announced today that its company name has changed to Evidence Clinical and Pharmaceutical Research (Evidence CPR). Chairman and CEO Dr. Sergei Varshavsky said: "The new name, Evidence CPR, accentuates the scientific cornerstone of the company standards: gathering evidence to assist doctors, patients and society as a whole in achieving safe and effective methods of combating disease."

Known since 1989 as a full-service contract research organization (CRO) conducting multinational clinical trials in Eastern Europe and Russia, today Evidence Clinical and Pharmaceutical Research is positioned better than ever to gather evidence on the safety and efficacy of medicines. In furtherance of the company goal of becoming the leading CRO in Russia and Eastern Europe, and continuing to achieve full client satisfaction, Evidence CPR recently combined its worldwide operations under one roof by bringing together DWCC - U.S, DWCC - Georgia and CPR - Russia.

Company hallmarks -- swift patient recruitment, high quality of data, flexibility, transparency, leading-edge technologies, responsible, highly-trained professional staff, and involvement in an ever-expanding range of medical areas have earned Evidence the satisfaction of its clients, well-documented over the years.

Here is what some of Evidence clients have said:

"The sites you recruited are now enrolling patients at or above the average rate we expected. We also have been very impressed by the timelines and quality of the data entry and data control procedures thus far, as well as by your understanding of the protocol. So far your sites have shown remarkable compliance to the protocol." Michael Domanski, MD, Head, Clinical Trials Scientific Research group, NHLBI, Department of Health & Human Services.

"CPR/DWCC showed superior attention to detail, clear experience, optimistic yet honest assessments of timelines and enrollment, and the necessary understanding to a sponsor's first forays into the conduction of GCP trials in Russia and Georgia. DWCC/CPR are very well resourced and most definitely put the necessary priority on ICH GCP when selecting sites, providing investigator training and during the monitoring process. Furthermore, perhaps DWCC/CPR's biggest strengths are their excellent communication skills, their commitment to providing comprehensive and quality service to the client and their tremendous experience in cardiology. We hope to engage DWCC/CPR for a multitude of trials in the years to come." Rafael Escandon, Senior Manager, CV Therapeutics.

"Based on our experience to date, I would not hesitate to use this organization again, and I would highly recommend them for clinical research services in Russia and Eastern Europe." Sonja McKinlay, PhD, President, New England Research Institutes, Watertown, MA.